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Background 
 
Recently, the discovery of the mevalonate-independent 
pathway for isoprenoid biosynthesis opened interesting 
opportunities for the discovery of new antimalarial agents, as 
this alternative pathway is absent in humans. Two groups 
simultaneously discovered that fosmidomycin (1) potently 
inhibits 1-deoxy-D-xylulose 5-phosphate reductoisomerase 
(DXR),
1
 which converts 1-deoxy-D-xylulose 5-phosphate 
(DOXP) to 2C-methyl-D-erithrytol phosphate (MEP), the 
second step in the non-mevalonate pathway. Its acetyl 
counterpart FR900098 (2) exhibits potent inhibition of DXR, 
and the former is currently in clinical trials of combination 
therapies for the treatment of malaria. They thus represent 
valuable leads, for further optimization in the quest for new 
antimalarials. 
                                                                                                                               
 
 
 
 
 
Aim 
 
Attempts to increase their potency by introducing various 
aromatic groups in -position of the phosphonate, yielded 
analogues with increased cell-based activity.
2
 Remarkably, 
substitution at the -position has hitherto not been explored. 
In this poster, we present our ongoing efforts towards the 
synthesis of -substituted analogues (3).  
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 Methods-retrosynthesis 
 
Conjugate addition of dibenzyl methylphosphonate to 
cinnamic hydroxamates or esters, offers a short synthetic 
plan, which also allows late introduction of the phosphonate 
moiety to yield a modified three carbon linker and 
hydroxamate of 3. Thus, treatment of various cinnamic acids 
with N-methyl,O-benzylhydroxylamine affords appropriate 
intermediates 11 which serve as Micheal acceptors for 
complimentarily protected phosphonate donors. A single 
benzyl deprotection step of 10 would then give access to the 
desired target compounds 4 - 9. 
 
Results and conclusion  
 
A short synthetic plan for modifying the three carbon spacer 
of FR900098 at the beta position has been developed and 
successfully executed. Biological evaluation will follow. 
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4 R1 = Cl  R2 = H
5 R1 = Cl  R2 = Cl
6 R1 = Br R2 = H
7 R1 = OMe R2 = H
8 R1 = H      R2 = H
9 R1 = Me    R2 = H
